Other Rules

The Office of MaineCare Services, formerly the Bureau of Medical Services, Division of Policy and Provider Services performs rulemaking to implement and update policies for the programs listed below. Adopted rules for these programs are available on the Secretary of State (SOS) website. 

  • Maine State Services Manual - MaineRX and DEL (10-144, Department of Health and Human Services, Chapter 104)
  • Medical Eye Care (10-144, Department of Health and Human Services, Chapter 107)
  • Quality Oversight for Commercial Health Maintenance Organizations (10-144, Department of Health and Human Services, Chapter 109)
  • Free Care Guidelines (10-144, Department of Health and Human Services, Chapter 150)
  • Maine Certificate of Need Procedures Manual for Health Care Facilities - Other Than Nursing Care Facilities (10-144, Department of Health and Human Services, Chapter 503)

Proposed, recently adopted and emergency rules for the programs are posted below. Any policy clarifications regarding adopted policies are also posted below.

Note: Although adopted rules are posted on the SOS website, there is always a delay between the effective date the Office of MaineCare Services adopts a rule and the date it is posted on the SOS website. Therefore, the Office of MaineCare Services posts recently adopted rules here until they are posted on the SOS website.

For information regarding Manufacturer Prescription Drug Fees

*free viewer or to request a hard copy

 

Proposed Other Rules

Department of Health and Human Services, Chapters 275, Sections 1-3, Reporting and Fee Requirements for Pharmaceutical Manufacturers and Labelers-Joint rule withOffice of the Attorney General, Chapter 111, Reporting Requirements for Pharmaceutical Manufac WORD  PDF 
Concise Summary: This proposed rule adopts an emergency rule that repeals Chapter 275; Section 1-Prescription Drug Clinical Trial Reporting, Section 2-Reporting of Prescription Drug Marketing Costs and Section 3-Fee Provision to implement Prescription Privacy Laws. The 125th Maine Legislature enacted PL 2007 on June 29, 2011, which repealed the statutory provisions that authorized the Department to require marketing and clinical drug trial reporting and that supported the Attorney General’s position in adopting clinical drug trial reporting requirements as a trade practice. In addition, the federal District Court rendered a decision that the Maine prescription drug privacy statutory provision is unconstitutional, following a recent Supreme Court decision.
Submit Comments (Opens in new window) - Comment Deadline: December 15, 2011 Posted: November 15, 2011
 
Department of Health and Human Services, Chapter 107, Medical Eye Care Program WORD  PDF 
Concise Summary: The Department is filing this proposed rule to adopt an earlier emergency rule to repeal 10-144, Chapter 107, Medical Eye Care Program because this program is a state funded DHHS benefit that has not had state funding since the previous fiscal year. There are no additional state funds to continue this program.
Submit Comments (Opens in new window) - Comment Deadline: December 15, 2011 Posted: November 15, 2011
 

Proposed Other Rules Archives

Recently Adopted Other Rules

    Recently Adopted Other Rules Archives

    Emergency Other Rules

    Department of Health and Human Services-General; Chapter 275-Reporting and Fee Requirements for Pharmaceutical Manufacturers and Labelers - Joint Rule with Dept. of Atty. General (Ch 111) WORD  PDF 
    Concise Summary: This emergency rule repeals Office of the Attorney General Chapter 111, Reporting Requirements for Pharmaceutical Manufacturers and Labelers, and Department of Health and Human Services Chapter 275, Section 1-Prescription Drug Clinical Trial Reporting, Section 2-Reporting of Prescription Drug Marketing Costs and Section 3-Fee Provision to implement Prescription Privacy Laws. The 125th Maine Legislature enacted PL 2007 on June 29, 2011, which repealed the statutory provisions that authorized the Department to require marketing and clinical drug trial reporting and supported the Attorney General’s position in adopting clinical drug trial reporting requirements as a trade practice. In addition, the federal District Court rendered a decision that the Maine prescription drug privacy statutory provision is unconstitutional, following a recent Supreme Court decision.
    Effective Date: November 8, 2011
     
    Department of Health & Human Services, Chapter 107, Medical Eye Care Program WORD  PDF 
    Concise Summary: The emergency adopted rule repeals 10-144, Chapter 107, Medical Eye Care Program, as it is a state funded DHHS benefit that has not had funding since the previous fiscal year. No additional funds are available for this program in the upcoming state fiscal years.
    Effective Date: November 8, 2011
     

    Emergency Other Rules Archives